Silver Book Fact

New medicines, or “new chemical entities” accounted for 40% (0.8 years) of the two-year gain in life expectancy seen in 52 countries from 1986-2000.

Lichtenberg, Frank R. The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001. National Bureau of Economic Research. June 2003; Working Paper No. 9754. http://www.nber.org/papers/w9754

Reference

Title
The Impact of New Drug Launches on Longevity: Evidence from longitudinal disease-level data from 52 countries, 1982-2001
Publication
National Bureau of Economic Research
Publication Date
June 2003
Authors
Lichtenberg, Frank R
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • “In 1985, the age adjusted nursing home residence rate was 54 people per 1,000 age 65 and over. By 2004 this rate had declined to 35 people per 1,000. Among…  
  • During the twentieth century, cumulative gains in life expectancy, for both men and women, were worth over $1.2 million per person.  
  • For each $1 spent on newer pharmaceuticals. $6.17 is saved in total health care spending. $4.44 of this savings is in hospital spending alone.  
  • Delaying the onset of Alzheimer’s disease, innovations that delay disability among the elderly through 2009, and a 25% increase in efficiency and effectiveness of cancer treatment would save $138 billion…  
  • Changes in behavior, preventative measures and innovation could save $1.6 trillion in treatment costs.